Spectral AI Inc.(MDAI)
USD --+0.00%
Reward48Moderate
Risk61Medium-High
📊75%Data
Thin -71% profit margin · Revenue down 54% YoY
MDAI
+0.0 · +0.00%
USD · NASDAQ
Spectral AI Inc. | Healthcare
Earnings Deterioration
Market Cap:43.58M
ℹ️
Reward Rating
48
Moderate
Bottom 25% (model universe)
75% data coverage
ℹ️
Risk Rating
61
Medium-High
Risk Assessment
ℹ️

Educational tool only – Scores are based on historical data and financial metrics for informational purposes. This is not financial advice or a recommendation to buy or sell any security. Always conduct your own research or consult a qualified financial adviser.

ℹ️ Educational tool only · More
Limited data coverage
We don't have enough public data on MDAI to score it reliably yet — Reward, Risk, Forecasts and Dividends tabs aren't available for this stock. The price chart and basic profile are still shown.
OTC / ADR stock — scores and fundamentals use data tagged in USD by our provider. The issuer may report in a different home currency (e.g. JPY), so treat figures as directional rather than precise.
Not available for limited-coverage stocks
The overview tab requires fundamentals and price history we don't have for this stock. The price chart is the most reliable view we have — try the Chart tab.

Market Performance

Stock returned +10.0% over the past year, broadly in line with market conditions.

Analyst Target

Analyst consensus price target: $5.36.

What is Spectral AI Inc.?

, an artificial intelligence (AI) company, focuses on predictive medical diagnostics in the United States.

MDAI · Verdict

Moderate reward · elevated risk

MDAI's standout is valuation; profitability and cash flow weigh on the picture.

Based on 88% data coverage

MDAI · Verdict

What’s working & what to watch

Strengths 1

  • Valuation67/100

    P/E 36.8×

Watchouts 3

  • Profitability19/100

    -52% net margin · -2308% ROE

  • Cash flow29/100

    -31% free-cash-flow margin

  • Balance sheet44/100

    Current ratio 0.57

Model-based scoring. For information only — not financial advice.

What is Spectral AI Inc.?

, an artificial intelligence (AI) company, focuses on predictive medical diagnostics in the United States. The company offers DeepView System, which uses proprietary AI algorithms to distinguish between fully damaged, partially damaged, and healthy human tissue characteristics invisible to the naked eye at the initial time point of wound presentation; and delivers a binary prediction on the wounds capacity to heal or not heal by a specified time point in the future to assist the physician in making a more accurate, timely, and informed decision regarding the treatment of the patient's wounds. The company is listed on the NASDAQ in USA, operating in the Healthcare sector, with a market capitalisation of 43.58M.

Financial Highlights

Investment Breakdown

📈 Growth
Moderate growth momentum — positive trajectory without breakout acceleration.
💰 Profitability
Thin or inconsistent margins weigh on earnings quality.
⚠️ Risk
Moderate volatility with meaningful macro and earnings sensitivity.
💸 Valuation
Valuation is less clear with a negative earnings base.

OpenBook Logo Analysis

Reward: Moderate (48)

The scoring profile indicates limited reward potential at this time, with valuation and growth offering the most support. Risk indicators are elevated — volatility and macro sensitivity warrant consideration.

For informational purposes only. Not financial advice.

Company Information
SectorHealthcare
Market Cap43.58M
P/E RatioN/A
Dividend YieldN/A
52 Week High3.21
52 Week Low1.04
Last AnnualDecember
IPO Date4/6/2021
IncorporatedUSA
Shares Outstanding31M
No. of Employees78
IndustryMedical Devices
ExchangeNASDAQ
Beta0.947
CurrencyUSD